Abstract:Introduction: Vascular remodeling after injury participates in several atherosclerotic cardiovascular diseases. Vascular progenitors are thought to play vital roles in vascular remodeling, while the specific contribution of newly-generated progenitors from non-progenitors after injury is neglected. Methods: We generated a Cd34 lineage tracing system and marked newly-generated CD34 + cells in vascular injury models. Single-cell transcriptomes revealed cellular changes of CD34 + cells during vascular remodeling. To explore the cell origin of these CD34 + cells, we applied bone marrow (BM) transplantation, pseudo-time analysis of femoral artery cells, and further generated a smooth muscle (SM) lineage tracing system. To examine the role of Doublecortin Like Kinase 1 (DCLK1) in SM-derived CD34 + cell generation, overexpression of DCLK1 in primary VSMCs and genetic knockout of DCLK1 in SM lineage tracing system was performed. Results: A cluster of CD34 + cells was identified in femoral artery wire injury, which were CD34 negative before injury but CD34 positive after injury. These newly-generated CD34 + cells co-expressed VSMC or immune cell markers in neointima. BM transplantation clarified that vascular resident newly-generated CD34 + cells expressed VSMC makers or CD68, while BM CD34 + cells turned to immune cells but not VSMCs in neointima. These non-BM newly-generated CD34 + cells partly derived from VSMCs after injury. DCLK1 expression increased along the VSMCs-to-CD34 + cells transition. DCLK1 overexpression in VSMCs increased progenitor cell marker expression and decreased contractile VSMC marker expression. Genetic depletion of DCLK1 in VSMCs impaired SM-derived CD34 + cell generation during vascular remodeling. Conclusions: A novel cluster ‘SM-derived CD34 + cells’ was defined after vascular injury. These findings enriched our knowledge in pathological process of vascular remodeling and provided an avenue for future clinical interventions.

How vascular smooth muscle cell phenotype switching contributes to vascular disease

Dedifferentiation of Vascular Smooth Muscle Cells Upon Vessel Injury

Vascular Smooth Muscle Cells Phenotypic Switching in Cardiovascular Diseases

An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis

Vascular smooth muscle cell phenotypic switching in atherosclerosis

Smooth Muscle Heterogeneity and Plasticity in Health and Aortic Aneurysmal Disease

Phenotypic switching of vascular smooth muscle cells in atherosclerosis, hypertension, and aortic dissection

Abstract 12723: Smooth Muscle-Derived CD34 + Cells after Vascular Injury Contribute to Vascular Remodeling

An overview of potential molecular mechanisms involved in VSMC phenotypic modulation

Single-cell RNA sequencing reveals the vascular smooth muscle cell phenotypic landscape in aortic aneurysm

The Expanding Role of Alternative Splicing in Vascular Smooth Muscle Cell Plasticity

Role of Vascular Smooth Muscle Cell Phenotypic Switching in Plaque Progression: A Hybrid Modeling Study

Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis

The Phenotypic Responses of Vascular Smooth Muscle Cells Exposed to Mechanical Cues

Pressure and stiffness sensing together regulate vascular smooth muscle cell phenotype switching

Impaired Autophagy Mediates Hyperhomocysteinemia-Induced HA-VSMC Phenotypic Switching

MicroRNA regulation of phenotypic transformations in vascular smooth muscle: relevance to vascular remodeling.

Long Noncoding RNA Function in Smooth Muscle Cell Plasticity and Atherosclerosis

Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease

New Insights into Phenotypic Switching of VSMCs Induced by Hyperhomocysteinemia: Role of Endothelin-1 Signaling

A regulator of G protein signaling 5 marked subpopulation of vascular smooth muscle cells is lost during vascular disease